Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/EUCTR2007-003483-22-NL
EUCTR2007-003483-22-NLActive, not recruitingNot Applicable

a double blind randomized study on the effectiveness of cyclopentolate 1% and cyclopentolate 1% with tropicamide 1% in dark irided hypermetropic children - effectiveness of cycloplegics

Medisch Centrum Haaglanden0 sites45 target enrollmentStarted: October 24, 2007Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Enrollment
45
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
All

Inclusion Criteria

  • •Healthy; not suffering from syndromes or diseases, 3 to 6 years (not attending groups three of the Dutch primary school system) old very dark irided hypermetropic children, possesing good accommodation, with no glasses prior or who did not wear their hypermetropic glasses since at least 4 weeks and able to fixate with each eye.
  • •Are the trial subjects under 18? yes
  • •Number of subjects for this age range:
  • •F.1.2 Adults (18-64 years) no
  • •F.1.2.1 Number of subjects for this age range
  • •F.1.3 Elderly (>=65 years) no
  • •F.1.3.1 Number of subjects for this age range

Exclusion Criteria

  • •Not healthy, e.g. suffering from syndromes or diseases, very dark irided hypermetorpic children, possessing good accommodation, aged 3 to 6 years. Or healthy very dark irided hypermetropic children, aged 3 to 6 years but visiting the third year of Dutch primary school. Hypoaccommodation. Wearing glasses. Not able to fixate with each eye.
  • •E.g. children not possessing the inclusioncriteria mentioned in E.3

Investigators

Similar Trials

Completed
Not Applicable
A double blind randomized study on the effectiveness of cyclopentolate 1% and cyclopentolate 1% with tropicamide 1% in dark irided hypermetropic childreEye strenght. Refraction10047518
NL-OMON30949Medisch Centrum Haaglanden45
Not yet recruiting
Phase 2
Homoeopathic Treatment of Piles.
CTRI/2024/06/068239The Calcutta Homoeopathic Medical College and Hospital
Active, not recruiting
Not Applicable
A double blind randomized study on the efficacy of cyclopentolate 1% and cyclopentolate 1% with tropicamide 1% in children - Efficacy of cycloplegicsDepth of cycloplegiachanges of astigmatismrecuperation from cycloplegia and mydriasisMedDRA version: 12.1Level: LLTClassification code 10011719Term: CycloplegiaMedDRA version: 12.1Level: PTClassification code 10011719Term: Cycloplegia
EUCTR2010-021410-34-NLMedical Centre Haaglanden423
Completed
Phase 3
A double blind randomized study on the efficacy of cyclopentolate 1% and cyclopentolate 1% with tropicamide 1% in childre
NL-OMON34025Medisch Centrum Haaglanden419
Active, not recruiting
Phase 1
Efficacy and Safety of REGN727 added-on to Rosuvastatin versus Ezetimibe added-on to Rosuvastatin versus Rosuvastatin dose increase in patients who are not controlled on RosuvastatiPatients with Non-familial hypercholesterolemia or heterozygous familial hypercholesterolemia (heFH) at high CV risk who are not adequately controlled with rosuvastatin (10mg or 20mg) with or without other lipid-modifying therapy (LMT) (excluding EZE)MedDRA version: 14.1Level: PTClassification code 10020603Term: HypercholesterolaemiaSystem Organ Class: 10027433 - Metabolism and nutrition disorders
EUCTR2012-002333-11-ESRegeneron Pharmaceuticals, Inc.305